GlassScriptPhysician profile
Alexandra Madden
NPI 1932972155
$704.62
in general payments reported to CMS, 2019-2025
11 companies · $478 in 2025
The $478 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $226 · 2025: $478.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $110.87 | 2025 | Ozempic |
| One Lambda, INC. | $100.60 | 2024 | |
| Abiomed | $100.16 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.39 | 2025 | Ofev, Jardiance |
| United Therapeutics Corporation | $87.72 | 2025 | Tyvaso, Steen Solution |
| Novartis Pharmaceuticals Corporation | $74.03 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $36.26 | 2024 | Wainua |
| Takeda Pharmaceuticals U.S.A., INC. | $34.33 | 2025 | Livtencity |
| Scpharmaceuticals INC. | $29.19 | 2025 | |
| Daiichi Sankyo INC. | $26.77 | 2025 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.30 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.